NASDAQ$ENSG
The Ensign Group Inc. · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Ensign Group reported a record quarter driven by consistent clinical and financial performance, with significant growth in same store occupancies and skilled mix days. The company raised its annual earnings and revenue guidance.
The Ensign Group reported strong third quarter results with GAAP diluted earnings per share of $1.34 and adjusted earnings per share of $1.39. Consolidated GAAP and adjusted revenue for the quarter were both $1.08 billion, an increase of 15.0% over the prior year quarter. The company raised its annual earnings guidance to between $5.46 to $5.52 per diluted share and revenue guidance to between $4.25 billion to $4.26 billion.
- GAAP net income increased by 22.8% over the prior year quarter.
- Same Facilities occupancy increased by 2.8% over the prior year quarter.
- Consolidated GAAP and adjusted revenue increased by 15.0% over the prior year quarter.
- The Company raised annual earnings and revenue guidance.
Headline financials
Revenue & EPS history
Ensign Group · Revenue · Quarterly
$1.08B
Revenue by segment
Ensign Group · $924M total across 2 segments · Q3 2023
- Skilled Services$903M+22.1%97.7%
- Standard Bearer$21M+12.3%2.3%
Forward guidance
The company raised its annual 2024 earnings guidance to between $5.46 to $5.52 per diluted share, up from $5.38 to $5.50 per diluted share. The company is also increasing its annual revenue guidance to between $4.25 billion to $4.26 billion, up from its previous guidance of $4.20 billion to $4.22 billion.
Tailwinds
- Solid skilled mix and occupancy growth during the quarter.
- Continued strength from recent acquisitions.
- New midpoint of 2024 earnings guidance represents an increase of more than 15.1% of 2023 results and is 32.6% higher than 2022 results.
- Anticipate closing additional acquisitions by the end of the year.
- Strong liquidity with approximately $532.1 million of cash on hand and $572.1 million of available capacity under its line-of-credit.
Headwinds
- Guidance assumes normalized health insurance costs.
- Guidance assumes current expectations regarding reimbursement rates.
- Guidance excludes certain charges that arise outside of the business.
- Guidance excludes acquisition related costs.
- Guidance excludes share-based compensation.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q3 2024
+1.7%
Avg return
Earnings day
+2.4%
Avg return
5 days after
+4.9%
Avg return
30 days after
55%
36 / 66 earnings
Positive
+21.1%
Q2 2020
Best reaction
-14.9%
Q4 2016
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -1.2% | -5.8% | -10.2% | |
| Q4 2025 | +13.8% | +17.8% | +19.7% | |
| Q3 2025 | -0.1% | -2.1% | -3.2% | |
| Q2 2025 | +0.1% | +1.8% | +1.2% | |
| Q1 2025 | +0.7% | +2.9% | +14.9% | |
| Q4 2024 | -8.7% | -13.3% | -12.4% | |
| Q3 2024 | +1.9% | +4.6% | -2.4% | |
| Q2 2024 | +4.5% | +6.5% | +8.4% | |
| Q1 2024 | -1.5% | -2.0% | +2.4% | |
| Q4 2023 | +6.7% | +3.9% | +7.7% | |
| Q3 2023 | -1.4% | -1.4% | +13.3% | |
| Q2 2023 | +1.4% | +3.2% | +7.0% | |
| Q1 2023 | -5.7% | -4.6% | -13.1% | |
| Q4 2022 | -1.7% | -4.4% | -2.7% | |
| Q3 2022 | -1.9% | +1.8% | +6.7% | |
| Q2 2022 | +9.5% | +6.5% | +7.0% | |
| Q1 2022 | -1.4% | -3.8% | +1.1% | |
| Q4 2021 | +7.9% | +6.0% | +15.9% | |
| Q3 2021 | +8.3% | +11.3% | +10.6% | |
| Q2 2021 | -2.5% | -1.3% | -3.8% | |
| Q1 2021 | -3.3% | -2.5% | -6.3% | |
| Q4 2020 | +0.4% | -2.1% | -6.3% | |
| Q3 2020 | +2.8% | +4.8% | +23.2% | |
| Q2 2020 | +21.1% | +21.5% | +20.9% | |
| Q1 2020 | +2.6% | +2.6% | +22.6% | |
| Q4 2019 | +11.6% | +13.9% | -2.5% | |
| Q3 2019 | +1.1% | +1.9% | +3.9% | |
| Q2 2019 | -10.3% | -15.7% | -17.2% | |
| Q1 2019 | -1.0% | +5.0% | +4.2% | |
| Q4 2018 | +11.3% | +10.0% | +10.2% | |
| Q3 2018 | +11.2% | +20.5% | +21.1% | |
| Q2 2018 | -2.7% | -0.1% | +8.4% | |
| Q1 2018 | +12.4% | +17.8% | +30.7% | |
| Q4 2017 | +7.5% | +8.7% | +20.1% | |
| Q3 2017 | -0.8% | -0.2% | -2.9% | |
| Q2 2017 | -7.4% | -7.3% | -4.4% | |
| Q1 2017 | +10.4% | +9.5% | +2.4% | |
| Q4 2016 | -14.9% | -15.5% | -8.9% | |
| Q3 2016 | +3.4% | +5.3% | +20.7% | |
| Q2 2016 | -12.2% | -8.9% | -12.6% | |
| Q1 2016 | +1.1% | — | — | |
| Q4 2015 | -5.6% | — | — | |
| Q3 2015 | +13.0% | — | — | |
| Q2 2015 | -0.8% | — | — | |
| Q1 2015 | +5.7% | — | — | |
| Q4 2014 | -6.0% | — | — | |
| Q3 2014 | +5.3% | — | — | |
| Q2 2014 | -1.9% | — | — | |
| Q1 2014 | -2.0% | — | — | |
| Q4 2013 | -1.0% | — | — | |
| Q3 2013 | +3.5% | — | — | |
| Q2 2013 | -3.9% | — | — | |
| Q1 2013 | -5.3% | — | — | |
| Q4 2012 | +3.1% | — | — | |
| Q3 2012 | -5.1% | — | — | |
| Q2 2012 | +2.6% | — | — | |
| Q1 2011 | -0.7% | — | — | |
| Q1 2012 | -0.7% | — | — | |
| Q4 2011 | +7.7% | — | — | |
| Q4 2009 | +7.7% | — | — | |
| Q3 2011 | +12.7% | — | — | |
| Q3 2010 | +12.7% | — | — | |
| Q4 2010 | +1.2% | — | — | |
| Q2 2010 | +1.2% | — | — | |
| Q2 2011 | +1.2% | — | — | |
| Q1 2010 | -3.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro